PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Half of all patients with sepsis die within two years

2024-10-14
(Press-News.org) Copenhagen, Denmark: Half of all patients with sepsis admitted to an emergency medical department died within two years, according to Danish researchers investigating factors that could predict outcomes for these patients.

 

Dr Finn E. Nielsen, a senior scientist in the Department of Clinical Epidemiology at Aarhus University Hospital, Denmark, told the European Emergency Medicine Congress today (Tuesday) [1] that he and his colleagues examined deaths over a long follow-up period in a prospective study of 714 adult patients admitted to the emergency department with sepsis. Their findings revealed several risk factors associated with sepsis-related deaths.

 

“We found that certain factors increased the risk of death after sepsis, including, not surprisingly, advanced age. Additionally, conditions such as dementia, heart disease, cancer and previous hospitalisation with sepsis within the last six months before admission also elevated the risk of dying during a median follow-up period of two years,” he said. [2]

 

In a report in 2020, the World Health Organization (WHO) highlighted limitations and gaps in knowledge about sepsis outcomes, with existing studies having a mixture of designs, differences in data sources, and different definitions of sepsis, all of which produced considerable variations in estimates of incidence and deaths from the condition. The WHO called for prospective studies to investigate long-term outcomes for sepsis patients.

 

Dr Nielsen, who is a specialist in emergency medicine, cardiology and internal medicine, established the sepsis research group in his emergency department in 2017. The current study examined outcomes among patients admitted with sepsis between October 2017 and the end of March 2018.

 

“Our study relied on a sepsis database, which provided valuable information based on prospectively collected patient data. Unlike frequently used routine registry data, this approach minimised errors, and allowed for more accurate and detailed insights into sepsis effects.”

 

A total of 2,110 patients with suspected infections were included in the study, of whom 714 developed sepsis. The researchers obtained data on deaths from the Danish registry systems, which provide up-to-date information on all Danish citizens. They found that after a median of two years, 361 (50.6%) of the patients with sepsis had died from any cause, including sepsis. Older age increased the risk of death by 4% for every additional year of age.

 

Furthermore, a history of cancer more than doubled the risk (121%), ischaemic heart disease (a condition in which the arteries supplying blood to the heart narrow or become blocked by a build-up of fat) increased the risk by 39%, dementia increased the risk by 90%, and previous admission with sepsis within the last six months increased the risk by 48%.

 

“Our study identifies several risk factors that should be prioritised by medical staff for information, care and follow-up checks. We believe this knowledge is useful for both clinicians and researchers in the field of acute medicine,” said Dr Nielsen. “Recognising that sepsis is a serious illness with high mortality is crucial.”

 

As the study was carried out in a single centre, further research in larger, prospective studies is needed.

 

“In this study, we have attempted to address some of the gaps in our understanding of sepsis epidemiology. We have contributed with an investigation that, unlike many other studies, is based on prospective electronic health record-based research. Similar but larger studies of sepsis-related outcomes need to be repeated across departments, regions and countries to obtain a comprehensive epidemiological picture of sepsis, including the long-term prognostic aspects of physical, mental and cognitive disorders, and the potential impact of these factors on the risk of death,” he said.

 

Dr Nielsen and his colleagues tried to develop a model that could predict the risk of death over the longer term but found that its predictive power was not good enough.

 

“Although we identified several risk factors that clearly increased the risk of death and should provide a focus for clinicians and researchers during the discharge planning process, as well as for developing future prediction studies, we were unable to construct an overall model suitable for predicting mortality in clinical practice,” he said. “There is a need for prospective studies of the effect of other factors that are not examined in our study, including various complications that may arise following hospitalisation and after discharge.”

 

Dr Nielsen added: “We will be presenting supplementary data to the conference. Including a score for organ failure in a more complex model has improved the ability to predict the risk of long-term death after hospitalisation. This has potential applications in clinical practice and future research.”

 

Dr Barbra Backus is chair of the EUSEM abstract selection committee. She is an emergency physician in Rotterdam, The Netherlands, and was not involved with the research. She said: “Sepsis is a serious and potentially fatal medical condition. The incidence of sepsis is increasing in several countries, yet so far, there has been limited, reliable information about long-term outcomes for patients who develop sepsis. This study has shown certain risk factors that should alert clinicians to the risk of patients with sepsis at an increased risk of dying, so that they can monitor them and follow them up more closely. More research is needed to help us better understand the risk factors for an increased risk of dying from sepsis, which can help to improve treatment.”

 

(ends)

 

[1] Abstract no: OA058, “Long-term mortality among sepsis patients: A prospective single-center study”, by Finn E. Nielsen, in the Infectious Diseases oral abstracts session, Tuesday 15 October at 11:00 hrs CEST, Room 18.

[2] A “median” average is the middle number when a set of numbers are placed in order. In this study, some patients will have died before two years and some after. The range was one to 896 days.

END


ELSE PRESS RELEASES FROM THIS DATE:

Native Hawaiian and Pacific Islander adults have third highest cardiovascular death rate in the U.S.

2024-10-14
Embargoed for release until 5:00 p.m. ET on Monday 14 October 2024     @Annalsofim          Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.     ...

Gene therapy automatically converts omega-6 to omega-3 fatty acids in the body

2024-10-14
St. Louis, MO (October 14, 2024) According to the Centers for Disease Control, nearly 20% of children and teens are considered obese. Research shows it can have a dramatic impact on a variety of health conditions, including arthritis, heart conditions and other metabolic problems, and the American Academy of Pediatrics now recommends early and intensive treatment to combat obesity. Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity.    Using gene therapy, Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak and Senior Scientist Dr. Ruhang Tang ...

Mpox clinical presentation, diagnostic approaches, and treatment strategies

2024-10-14
About The Study: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox. Corresponding Author: To contact the corresponding author, Jason Zucker, MD, MS, email Jz2700@cumc.columbia.edu. To access the embargoed study: Visit our For The Media ...

Trends in oral and injectable HIV preexposure prophylaxis prescriptions in the US

2024-10-14
About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed medication since 2021. Injectable PrEP use was low likely because of barriers such as the high cost of stocking this expensive medication in clinics. Corresponding Author: To contact the corresponding author, Laura M. Mann, PhD, MPH, email lmann@cdc.gov. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.21493) Editor’s ...

Information about sexual and gender minority services and policies on US hospital websites

2024-10-14
About The Study: Most U.S. hospital websites explicitly included sexual and gender minority (SGM) populations in their nondiscrimination policies, but only a quarter of adult hospitals had an SGM-friendly clinician directory and provided information about SGM-related resources or hospital-based services. Pediatric hospitals more frequently posted SGM-related information than adult hospitals. Hospitals in states with more discriminatory policies were less likely to provide SGM-related information online. Corresponding Author: To contact the corresponding author, Alex S. Keuroghlian, MD, MPH, email akeuroghlian@mgb.org. To ...

Study finds use of naloxone by Good Samaritans is up, but not nearly enough

2024-10-14
Study finds use of naloxone by Good Samaritans is up, but not nearly enough Ohio State and National Registry of EMTs research highlights importance of public’s help in opioid overdose response COLUMBUS, Ohio – Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open from The Ohio State University College of Medicine, College of Public Health and the National Registry of Emergency Medical Technicians. In the first study of its kind, the research team looked at national use of naloxone by people without medical training to treat an opioid drug overdose.  “Naloxone ...

Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists

2024-10-14
About The Study: In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of suicidal ideation or attempts compared with matched patients not prescribed GLP1R who were treated with lifestyle intervention. These results suggest a favorable psychiatric safety profile of GLP1R in adolescents. The detected reduction in hazard ratios for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research. Corresponding Author: To contact the corresponding author, Liya Kerem, MD, MSc, email liya.em@gmail.com. To access the ...

SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients

2024-10-14
About The Study: In this retrospective cohort study of children and adolescents ages 10 to 19, the risk of an incident diagnosis of type 2 diabetes was greater following a COVID-19 diagnosis than in children diagnosed with other respiratory infections. Further study is required to determine whether diabetes persists or reverses later in life.  Corresponding Author: To contact the corresponding author, Pauline Terebuh, MD, MPH, email pdt@case.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.39444) Editor’s Note: Please see the article for additional information, ...

Recovery from COVID-19–related disruptions in cancer detection

2024-10-14
About The Study: This cross-sectional study of nationally representative registry data found that cancer incidence recovered meaningfully in 2021 following substantial disruptions in 2020. However, incidence rates need to recover further to address the substantial number of patients with undiagnosed cancer during the pandemic.  Corresponding Author: To contact the corresponding author, Uriel Kim, MD, PhD, MBA, email uxk13@case.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.39263) Editor’s Note: Please ...

Smaller vial size for Alzheimer’s drug could save Medicare hundreds of millions per year

2024-10-14
Medicare could save up to 74% of the money lost from discarded Alzheimer’s drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away, new research suggests. The researchers on the study, to be published October 14 in the peer-reviewed JAMA Internal Medicine, estimate that Medicare could waste up to $336 million annually due to discarded medication. Administered dosages are based on each patient’s body weight. But because the drug is currently available ...

LAST 30 PRESS RELEASES:

The distinct nerve wiring of human memory

Researchers discover new third class of magnetism that could transform digital devices

Personalized blood count could lead to early intervention for common diseases

Innovative tissue engineering: Boston University's ESCAPE method explained

Global healthspan-lifespan gaps among 183 WHO member states

Stanford scientists transform ubiquitous skin bacterium into a topical vaccine

Biological diversity is not just the result of genes

Analysis reveals an additional mechanism behind statin therapy’s heart-related benefits in people with HIV

Understanding how the immune system switches between rest and action

Wiley expands its KnowItAll solutions with new tools for LC-MS analysis, enterprise data management, and additional spectral advances

A new class of antivirals could help prevent future pandemics

Nature Biotechnology | Generative chemistry enables Insilico to develop gut-restricted PhD inhibitors promising for intestinal mucosal barrier repair and immunomodulation

2 U-M faculty members elected to National Academy of Inventors

Breakthroughs in cell-penetrating monoclonal antibody therapies

Accelerated aging in young sickle cell patients linked to elevated T-cell p16INK4a

Nanofluidic devices redefining matter manipulation at an unprecedented level

Powering the future together – Public-Private Collaboration for the energy transition in Finland

Exosome-mediated crosstalk in the tumor immune microenvironment: Critical drivers of hepatocellular carcinoma progression

JMIR Aging achieves top ranking, accepted into prestigious science citation indexes

Persistent tobacco smoking from childhood may cause heart damage by the mid-twenties

Smoking tobacco from childhood can cause premature heart damage

Southwest Research Institute seeks contractors worldwide to support Oil Sampling Program

Statistical and engineering approaches to federated learning: Comprehensive benchmarking for healthcare applications

AI can help us choose words more carefully when talking about addiction

Religious people are not more generous – with one exception

PARP inhibition shows long-term survival benefits for patients with high-risk, BRCA-positive breast cancer in OlympiA trial

BRCA-mutation carriers with a history of early-onset breast cancer may benefit from risk-reducing surgery

Next-generation SERD protects against progression in some patients with advanced breast cancer resistant to standard hormone therapy

Carnegie Mellon University Africa and Challenger Center collaborate to deliver STEM programs

Top five rising star Texas researchers named in 2025 Edith and Peter O’Donnell Awards by TAMEST

[Press-News.org] Half of all patients with sepsis die within two years